Literature DB >> 19048223

[Relevance of radiological imaging for lymph node surgery of urological tumors].

J Stattaus1, M Forsting.   

Abstract

This review illustrates the relevance of computed tomography (CT) and magnetic resonance imaging (MRI) for detecting or excluding lymph node metastases in urological malignancies. Although radiological assessment of lymph node metastases is well established in renal cell and testicular cancer, it is unreliable in prostate, bladder, and penile cancer. MR lymphography has shown promising results in these tumors, but because marketing authorization for the iron oxide contrast agent is lacking, it is not clinically applicable. Percutaneous CT-guided biopsy in the retroperitoneum and pelvis is introduced as an alternative in the histological exploration of suspicious lymph nodes.

Entities:  

Mesh:

Year:  2009        PMID: 19048223     DOI: 10.1007/s00120-008-1753-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  33 in total

Review 1.  State-of-the-art staging in prostate cancer.

Authors:  B A Wilkinson; F C Hamdy
Journal:  BJU Int       Date:  2001-03       Impact factor: 5.588

2.  High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma.

Authors:  C Catalano; F Fraioli; A Laghi; A Napoli; F Pediconi; M Danti; P Nardis; R Passariello
Journal:  AJR Am J Roentgenol       Date:  2003-05       Impact factor: 3.959

Review 3.  New imaging modalities in bladder cancer.

Authors:  Mansi A Saksena; Douglas M Dahl; Mukesh G Harisinghani
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 4.  Functional imaging in penile cancer: PET/computed tomography, MRI, and sentinel lymph node biopsy.

Authors:  Ullrich G Mueller-Lisse; Bernhard Scher; Michael K Scherr; Michael Seitz
Journal:  Curr Opin Urol       Date:  2008-01       Impact factor: 2.309

Review 5.  [Lymphatic metastases in renal cell carcinoma. What is the value of operation and adjuvant therapy?].

Authors:  G H Mickisch
Journal:  Urologe A       Date:  1999-07       Impact factor: 0.639

6.  Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.

Authors:  G J Jager; J O Barentsz; G O Oosterhof; J A Witjes; S J Ruijs
Journal:  AJR Am J Roentgenol       Date:  1996-12       Impact factor: 3.959

7.  Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.

Authors:  Willem M L L G Deserno; Mukesh G Harisinghani; Matthias Taupitz; Gerrit J Jager; J Alfred Witjes; Peter F Mulders; Christina A Hulsbergen van de Kaa; D Kaufmann; Jelle O Barentsz
Journal:  Radiology       Date:  2004-09-16       Impact factor: 11.105

Review 8.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

9.  Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.

Authors:  Steven E Canfield; Ashish M Kamat; Ricardo F Sánchez-Ortiz; Michelle Detry; David A Swanson; Christopher G Wood
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

10.  Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases.

Authors:  U E Studer; S Scherz; J Scheidegger; R Kraft; R Sonntag; D Ackermann; E J Zingg
Journal:  J Urol       Date:  1990-08       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.